483 related articles for article (PubMed ID: 9862728)
1. Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
Kessler B; Hudrisier D; Schroeter M; Tschopp J; Cerottini JC; Luescher IF
J Immunol; 1998 Dec; 161(12):6939-46. PubMed ID: 9862728
[TBL] [Abstract][Full Text] [Related]
2. The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
Hudrisier D; Kessler B; Valitutti S; Horvath C; Cerottini JC; Luescher IF
J Immunol; 1998 Jul; 161(2):553-62. PubMed ID: 9670927
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A.
Anel A; Buferne M; Boyer C; Schmitt-Verhulst AM; Golstein P
Eur J Immunol; 1994 Oct; 24(10):2469-76. PubMed ID: 7523141
[TBL] [Abstract][Full Text] [Related]
4. Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
Kessler BM; Bassanini P; Cerottini JC; Luescher IF
J Exp Med; 1997 Feb; 185(4):629-40. PubMed ID: 9034142
[TBL] [Abstract][Full Text] [Related]
5. CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts.
Doucey MA; Legler DF; Boucheron N; Cerottini JC; Bron C; Luescher IF
Eur J Immunol; 2001 May; 31(5):1561-70. PubMed ID: 11465114
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
7. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
8. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT; Morgan DJ; Krahl T; Ko A; Sarvetnick N; Sherman LA
J Immunol; 1999 Oct; 163(8):4335-41. PubMed ID: 10510373
[TBL] [Abstract][Full Text] [Related]
9. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity.
Kataoka T; Shinohara N; Takayama H; Takaku K; Kondo S; Yonehara S; Nagai K
J Immunol; 1996 May; 156(10):3678-86. PubMed ID: 8621902
[TBL] [Abstract][Full Text] [Related]
10. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
Asnagli H; Schmitt-Verhulst AM; Guimezanes A
J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
[TBL] [Abstract][Full Text] [Related]
11. Activated alpha beta-CD8+, but not alpha alpha-CD8+, TCR-alpha beta+ murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in Fas-based cytotoxicity.
Gelfanov V; Gelfanova V; Lai YG; Liao NS
J Immunol; 1996 Jan; 156(1):35-41. PubMed ID: 8598484
[TBL] [Abstract][Full Text] [Related]
12. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
[TBL] [Abstract][Full Text] [Related]
13. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
Williams NS; Engelhard VH
J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
[TBL] [Abstract][Full Text] [Related]
14. Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing.
Su MW; Pyarajan S; Chang JH; Yu CL; Jin YJ; Stierhof YD; Walden P; Burakoff SJ
Eur J Immunol; 2004 Sep; 34(9):2459-70. PubMed ID: 15307178
[TBL] [Abstract][Full Text] [Related]
15. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
[TBL] [Abstract][Full Text] [Related]
16. IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones.
Esser MT; Dinglasan RD; Krishnamurthy B; Gullo CA; Graham MB; Braciale VL
J Immunol; 1997 Jun; 158(12):5612-8. PubMed ID: 9190908
[TBL] [Abstract][Full Text] [Related]
17. Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.
Bachmann MF; Ohteki T; Faienza KM; Zakarian A; Kägi D; Speiser DE; Ohashi PS
J Immunol; 1997 Nov; 159(9):4165-70. PubMed ID: 9379009
[TBL] [Abstract][Full Text] [Related]
18. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells.
Williams NS; Engelhard VH
J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294
[TBL] [Abstract][Full Text] [Related]
19. Perforin and Fas induced by IFNgamma and TNFalpha mediate beta cell death by OT-I CTL.
McKenzie MD; Dudek NL; Mariana L; Chong MM; Trapani JA; Kay TW; Thomas HE
Int Immunol; 2006 Jun; 18(6):837-46. PubMed ID: 16574667
[TBL] [Abstract][Full Text] [Related]
20. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]